Investors are reacting to a proposed US bill that could slap a 500% tariff on many Indian imports, adding to the existing 50% duty and sending export‑focused stocks tumbling.
What the Bill Proposes
The legislation would allow the US President to levy a 500% tariff on goods from countries that purchase cheap Russian oil, including India. This would sit on top of the 50% tariffs already applied to many Indian products.
Market Reaction
Shares of textile, apparel, seafood and pharmaceutical exporters fell sharply on Thursday. Major textile exporters such as Gokaldas Exports, KPR Mill, Vardhman Textiles and Welspun Living dropped 2‑8%. Shrimp exporters Avanti Feeds, Apex Frozen Foods and Coastal Corporation also slipped 2‑8%. Even pharma firms like Dr Reddy’s Laboratories, Torrent Pharmaceuticals and Sun Pharmaceutical, which are currently exempt, fell 1‑3% as investors worry about future rules.
Analyst Viewpoint
Experts say the lack of clarity on the new tariffs is hurting confidence in a possible US‑India trade deal. They suggest investors focus on companies that serve the domestic market until the situation becomes clearer. Sectors such as IT and pharmaceuticals, which are not directly affected, may present buying opportunities after the initial panic.
What Retail Investors Can Do
- Wait for clearer guidance before betting on export‑oriented stocks.
- Consider buying shares of firms that sell mainly inside India, especially if they have solid fundamentals.
- Look at sectors that are unlikely to face tariffs, like IT services, for longer‑term positions.
Remember, this is perspective, not a prediction. Do your own research and consider your risk tolerance before making any investment decisions.